Bioassay
- Company typePrivate
- Founded2002
- HeadquartersHeidelberg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
Bioassay firmographics
Firmographics- Name
- Bioassay
- Legal name
- Bioassay GmbH
- Website
- https://bioassay-online.de
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Bioassay industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
- akta.pro secondary industries
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
Keywords
Where Bioassay is headquartered
LocationHeadquarters
- HQ city
- Heidelberg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Bioassay business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Research Services: B2B contract research services providing bioanalytical testing, assay development, validation, and routine testing for pharmaceutical and biotech companies. Revenue generated through project-based contracts for development, validation, and release testing services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Bioassay product offering
Product offeringCore offering
Bioassay GmbH is a bioanalytical contract research organization (CRO) that develops, validates, and performs routine testing of bioassays for biologics and drug products. Core offerings include potency assay development and execution, efficacy and safety assessment studies, physico-chemical HPLC analysis, GLP toxicology services, and GMP potency testing for veterinary biologics — all delivered under GMP and GLP certifications from a 2,000 m² facility in Heidelberg, Germany.
Product overview
Bioassay is a bioanalytical contract research organization offering a unified suite of services for biologics and drug product development. The core portfolio includes BioPharma Potency (potency assay development and execution for biologics and proteins), BioPharma Efficacy & Safety (efficacy models and safety assessment studies), Physico-Chemical Analysis (HPLC-based qualitative and quantitative analysis), GLP Services (acute toxicity and skin sensitization studies), and Veterinary Products (GMP potency testing for veterinary biologics). Supporting these service lines are assay development, validation, release testing, and stability studies capabilities. All services are performed under GMP and GLP certifications at their 2000 m2 facility in Heidelberg Technology Park.
Differentiator
Problem solved
Functional benefit
Products and services
- BioPharma Potency Develops and executes potency assays for biologics, proteins, and active pharmaceutical ingredients under established GMP quality guidelines. Used by pharmaceutical and biotech companies to evaluate potency of biologics from discovery through commercial release.
- BioPharma Efficacy & Safety Establishes efficacy models to test biosimilars or active pharmaceutical ingredients and offers safety assessment studies to support product registration. Used by pharma and biotech developers preparing regulatory submissions.
- Physico – Chemical Analysis Uses state-of-the-art, highly sensitive HPLC equipment for qualitative and quantitative analysis under both GMP and non-GMP conditions. Used by pharmaceutical companies requiring physico-chemical characterization of compounds.
- GLP Services Supports compound selection before registration with complementary in vitro/in vivo acute toxicity and skin sensitization services under GLP guidelines. Used by pharma and biotech companies preparing preclinical registration packages.
- Veterinary Products GMP potency testing services for veterinary biologics, ensuring animal veterinary products are safe and effective for use in animals. Used by veterinary biologics manufacturers for regulatory-compliant batch release testing.
Companies that use Bioassay
Customer profileSegments2 records
Ideal customer profiles2 records
Bioassay technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Bioassay partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Reaction BiologycoreBioassay GmbH is a subsidiary company of Reaction Biology. Reaction Biology operates as the parent company providing strategic direction and operational support for the bioanalytical services subsidiary.
Scale indicators1 record
Recent moves4 records
Expansion highlights3 records
Bioassay competitors and assessment
Company assessmentDirect peers
- Reaction Biology: Bioassay's parent company, Reaction Biology operates early-discovery CRO services with overlapping scientific talent and client base in bioanalytical and biologics testing. Closest organizational and commercial comparable.
- Bionova Scientific: Bionova Scientific is a GMP biologics-focused testing CRO offering cell-based potency, release, and stability services. A specialty peer with very similar scope and target customer profile.
- BioAgilytix: BioAgilytix specializes in bioanalytical services for biologics, including cell-based potency assays and immunogenicity. Closely comparable specialty CRO targeting the same biologics sponsors with similar assay modalities.
Emerging players
- NorthEast BioAnalytical Laboratories: NE BioLab provides regulated bioanalytical and potency assay services for biologics and biosimilars. Niche CRO comparable to Bioassay in scale and service mix.
- Sartorius (Bioprocess & Lab Products): While primarily a bioprocessing supplier, Sartorius operates in the cell-based assay and biologics characterization space, providing tools and increasingly services that overlap with Bioassay's potency assay work for cell and gene therapies.
Broad incumbents
- Charles River Laboratories: Charles River's Biologics Testing Solutions offer GMP lot-release, stability, and cell-based assay services. A broad incumbent competing for the same biologics sponsors with substantially greater geographic reach.
- Intertek Pharmaceutical Services: Intertek offers GMP bioanalytical, potency, and physico-chemical testing for biologics with global reach. Comparable to Bioassay in service scope and quality system positioning.
- Eurofins BioPharma Product Testing: Eurofins' BioPharma Product Testing network provides GMP potency, stability, and physico-chemical testing for biologics at global scale. Most direct large-scale competitor for Bioassay's core potency and release testing services.
- WuXi AppTec (Bioanalytical Services): WuXi AppTec offers large-scale GMP bioanalytical and biologics testing services globally. Competes for biologics potency and release testing work with significantly broader capacity than Bioassay.
- SGS Life Sciences: SGS provides GMP-compliant biologics testing, potency assays, and stability studies across a global lab network. Overlaps with Bioassay on regulated potency and release testing for biologics and vaccines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Bioassay social profiles
Digital presenceBioassay compliance and trust
Trust signalCompliance3 records
Bioassay financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioassay leadership team
Management profileNumber of profiles
Bioassay funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioassay M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioassay
What does Bioassay do?
Bioassay GmbH is a bioanalytical contract research organization (CRO) that develops, validates, and performs routine testing of bioassays for biologics and drug products. Core offerings include potency assay development and execution, efficacy and safety assessment studies, physico-chemical HPLC analysis, GLP toxicology services, and GMP potency testing for veterinary biologics — all delivered under GMP and GLP certifications from a 2,000 m² facility in Heidelberg, Germany.
Is Bioassay a public or private company?
Bioassay is a private company. It is classified as corporate owned and is currently operating.
When was Bioassay founded?
Bioassay was founded in 2002. It employs 11 to 50 people.
Where is Bioassay based?
Bioassay is headquartered in Heidelberg, Germany, in the Europe region.
How does Bioassay make money?
One revenue line is on record: contract Research Services.
Who are Bioassay's main competitors?
Direct peers on record are Reaction Biology, Bionova Scientific and BioAgilytix. Emerging players are NorthEast BioAnalytical Laboratories and Sartorius (Bioprocess & Lab Products). Broad incumbents are Charles River Laboratories, Intertek Pharmaceutical Services, Eurofins BioPharma Product Testing, WuXi AppTec (Bioanalytical Services) and SGS Life Sciences.
Does Bioassay have an API?
No public API is recorded for Bioassay.
What industry is Bioassay in?
Bioassay's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 5417 and its SIC code is 8731.